Mask-associated Dry Eye Symptoms in China
Sponsor
Tianjin Eye Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04744805
Collaborator
(none)
6,262
8
Study Details
Study Description
Brief Summary
To review the relationship of increased face mask usage arising from lockdown measures instituted during the COVID-19 pandemic with dry eye symptoms on Chinese people, and make recommendations for mitigating potential detrimental effects on dry eye symptoms.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
6262 participants
Observational Model:
Ecologic or Community
Time Perspective:
Cross-Sectional
Official Title:
Mask-associated Dry Eye Symptoms: an Online Survey of 6262 Chinese Persons
Anticipated Study Start Date
:
Jan 29, 2021
Anticipated Primary Completion Date
:
Feb 5, 2021
Anticipated Study Completion Date
:
Feb 6, 2021
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| mask wear
|
Other: face mask or not
long term face mask wear
|
| dry eye
|
Other: face mask or not
long term face mask wear
|
Outcome Measures
Primary Outcome Measures
- time of face mask wear [3 months]
Eligibility Criteria
Criteria
Ages Eligible for Study:
6 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- age >=8 years mental health
Exclusion Criteria:
- eye diseases mental or systemic diseases
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Tianjin Eye Hospital
Investigators
- Study Director: Yan Wang, director, Tianjin Eye Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Tianjin Eye Hospital
ClinicalTrials.gov Identifier:
NCT04744805
Other Study ID Numbers:
- 2021003
First Posted:
Feb 9, 2021
Last Update Posted:
Feb 9, 2021
Last Verified:
Feb 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: